Below are the most recent publications written about "Cannabinoid Receptor Agonists" by people in Profiles.
-
Deventer MH, Emanuele MC, Stang BN, Van Uytfanghe K, Masson J, Bouvot X, Lamoureux C, Proposito A, Reniero F, Holland MV, Krotulski AJ, Mannina L, Stove CP, Guillou C. Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA. Drug Test Anal. 2025 Sep; 17(9):1623-1639.
-
Norman C, Webling K, Kyslychenko O, Reid R, Krotulski AJ, Farrell R, Deventer MH, Liu H, Connolly MJ, Guillou C, Vinckier IMJ, Logan BK, NicDa?id N, McKenzie C, Stove CP, Gr?en H. Detection in seized samples, analytical characterization, and in vitro metabolism of the newly emerged 5-bromo-indazole-3-carboxamide synthetic cannabinoid receptor agonists. Drug Test Anal. 2024 Sep; 16(9):915-935.
-
Inan S, Ward SJ, Baltazar CT, Peruggia GA, Javed E, Nayak AP. Epicutaneous Sensitization to the Phytocannabinoid ?-Caryophyllene Induces Pruritic Inflammation. Int J Mol Sci. 2023 Sep 20; 24(18).
-
Loblundo C, Severa J, Peruggia GA, Black KR, Chandra S, Lata H, ElSohly M, Chapman MD, Deshpande DA, Nayak AP. Proteomics-Based Approach for Detailing the Allergenic Profile of Cannabis Chemotypes. Int J Mol Sci. 2023 Sep 11; 24(18).
-
Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Mastropietro KF, Suhandynata RT, Huestis MA, Grant I, Fitzgerald RL. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial. JAMA Psychiatry. 2023 09 01; 80(9):914-923.
-
Hudzik TJ, Huestis MA, Rossi SS, Schumacher YO, Harcourt P, Budgett R, Stuart M, Tettey J, Mazzoni I, Rabin O, Danion A, Culler M, Handelsman D, Thevis M, Kinahan A. Cannabis and sport: A World Anti-Doping perspective. Addiction. 2023 11; 118(11):2040-2042.
-
Norman C, Deventer MH, Dremann O, Reid R, Van Uytfanghe K, Guillou C, Vinckier IMJ, Nic Da?id N, Krotulski A, Stove CP. In vitro cannabinoid receptor activity, metabolism, and detection in seized samples of CH-PIATA, a new indole-3-acetamide synthetic cannabinoid. Drug Test Anal. 2024 Apr; 16(4):380-391.
-
Fitzgerald RL, Umlauf A, Hubbard JA, Hoffman MA, Sobolesky PM, Ellis SE, Grelotti DJ, Suhandynata RT, Huestis MA, Grant I, Marcotte TD. Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests. Clin Chem. 2023 07 05; 69(7):724-733.
-
Shah S, Schwenk ES, Sondekoppam RV, Clarke H, Zakowski M, Rzasa-Lynn RS, Yeung B, Nicholson K, Schwartz G, Hooten WM, Wallace M, Viscusi ER, Narouze S. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids. Reg Anesth Pain Med. 2023 03; 48(3):97-117.
-
Shah S, Schwenk ES, Narouze S. ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids: an infographic. Reg Anesth Pain Med. 2023 03; 48(3):119.